Menon, Deepak http://orcid.org/0000-0001-7360-417X
Bril, Vera http://orcid.org/0000-0002-5805-4883
Article History
Accepted: 25 April 2022
First Online: 31 May 2022
Declarations
:
: No funding was received for the publication of this review.
: Vera Bril has consulted for Grifols, CSL, UCB, Argenx, Takeda, Alnylam, Octapharma, Pfizer, Powell Mansfield Inc, Akcea, Ionis, Immunovant, Sanofi, Momenta, Roche, Janssen, Alexion, NovoNordisk. She has received research support from Alexion, Grifols, CSL, UCB, Argenx, Takeda, Octapharma, Akcea, Momenta, Immunovant and Ionis. Deepak Menon has nothing to disclose.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable
: Not applicable.
: Deepak Menon: design of work, acquisition, analysis and interpretation of data, drafting the work and revisions. Vera Bril: design of work, drafting the work, analysis of data, revising it critically and final approval of version to be published.
Free to read: This content has been made available to all.